| 000 | 03004nam a22003975i 4500 | ||
|---|---|---|---|
| 001 | 85046 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040452.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 151211s2016 gw | s |||| 0|eng d | ||
| 020 | _a9783319247380 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aQH450 _b.P384 2016 |
|
| 082 | 0 | 4 | _a579.135 |
| 245 | 1 | 0 |
_aPatho-Epigenetics of Infectious Disease _cedited by Janos Minarovits, Hans Helmut Niller |
| 250 | _a1st ed. | ||
| 260 |
_aCham _bSpringer International Publishing _c2016 |
||
| 300 |
_a1 recurso en línea (XV, 137 páginas) _b8 ilustraciones |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aAdvances in Experimental Medicine and Biology _x0065-2598 _v879 |
|
| 520 | 3 | _aEpigenetic modification of cellular genomes is a fascinating means of regulating tissue- and cell type-specific gene expression in all developmental stages of the life of an organism. Carefully orchestrated processes, such as DNA methylation and a plenitude of specific histone modifications secure the faithful transmission of gene expression patterns to progeny cells. Upon chronic infection, the epigenetic cellular balance can become disrupted and, in the long run, through the epigenetic reprogramming of host cell genomes, contribute to the malignant conversion of formerly healthy cells, in many cases preceded by the establishment of an epigenetic field of cancerization. The present volume undertakes to highlight the interactions of infectious pathogens and their effector molecules with the epigenetic regulatory machinery of the cell. Clearly, the recent take-off of epigenetics research did not leave Research on Infectious Diseases and Infection-Associated Cancer untouched. This resulted in a great many of clinically relevant data on understanding the molecular mechanisms of chronic infectious disease. Infectious pathogen- and disease-specific epigenetic alterations are already being used for the early detection of malignant disease and for the prediction of chemotherapy resistance or response to treatment. | |
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 942 |
_2lcc _cLE |
||
| 988 | _aEBOOK, asignarmaterias , EBSPRINGER | ||
| 650 | 0 | 4 |
_9495993 _aCiencias de la vida |
| 650 | 7 |
_9405049 _aMicrobiología médica _0comprobar BNE19900963008 _2embne |
|
| 700 | 1 |
_aMinarovits, Janos. _eeditor literario _997717 _0Local |
|
| 700 | 1 |
_aNiller, Hans Helmut. _eeditor literario _997718 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-24738-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9783319247380 | ||
| 907 |
_a.b12943241 _b10-10-17 _c21-11-16 |
||
| 998 |
_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0 |
||
| 945 |
_aQH450 .P384 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11587489 _z06-04-17 |
||
| 999 |
_c85046 _d85046 _x1 |
||